Postmarketing Clinical Study on AO-128

Trial Profile

Postmarketing Clinical Study on AO-128

Phase of Trial: Phase IV

Latest Information Update: 20 May 2016

At a glance

  • Drugs Voglibose (Primary)
  • Indications Glucose intolerance
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top